VRCA
Verrica Pharmaceuticals Inc. NASDAQ Listed Jun 15, 2018$8.24
Mkt Cap $87.8M
52w Low $3.28
75.8% of range
52w High $9.82
50d MA $5.83
200d MA $5.89
P/E (TTM)
-3.7x
EV/EBITDA
-5.4x
P/B
2.7x
Debt/Equity
0.1x
ROE
-72.3%
P/FCF
-5.0x
RSI (14)
—
ATR (14)
—
Beta
1.43
50d MA
$5.83
200d MA
$5.89
Avg Volume
122.9K
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
44 West Gay Street · West Chester, PA 19380 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | AMC | -0.43 | -0.56 | -30.2% | 6.26 | -1.6% | -1.8% | -2.4% | -1.4% | +0.8% | -8.8% | — |
| Nov 14, 2025 | AMC | -1.14 | 0.13 | +111.4% | 3.93 | -2.3% | -5.1% | -2.5% | +14.0% | +2.3% | +7.1% | — |
| Aug 12, 2025 | AMC | -0.70 | 0.02 | +102.9% | 6.82 | +3.4% | -3.4% | -9.8% | -12.6% | -9.7% | -11.3% | — |
| May 13, 2025 | AMC | -1.40 | -1.00 | +28.6% | 5.50 | +0.0% | -2.7% | +16.7% | +20.4% | +17.1% | +16.9% | — |
| Mar 11, 2025 | AMC | -0.25 | -0.24 | +4.0% | 6.48 | -2.9% | -7.6% | -8.8% | -17.1% | +0.5% | +0.3% | — |
| Nov 4, 2024 | AMC | -0.37 | -0.49 | -32.4% | 14.30 | -35.0% | -44.2% | -47.8% | -50.8% | -42.0% | -32.7% | — |
| Aug 14, 2024 | AMC | -0.43 | -0.31 | +27.9% | 31.20 | +7.1% | -6.7% | -10.3% | -5.1% | -9.3% | -6.7% | — |
| May 13, 2024 | AMC | -0.54 | -0.38 | +29.6% | 95.60 | +4.0% | -0.7% | -4.8% | -4.3% | -9.3% | -9.0% | — |
| Feb 29, 2024 | AMC | -0.47 | -0.48 | -2.1% | 52.70 | +2.8% | +5.3% | +5.3% | -2.5% | -5.7% | -7.8% | — |
| Nov 9, 2023 | AMC | -0.22 | -0.32 | -45.5% | 32.10 | -0.9% | -4.2% | -6.2% | -8.7% | -1.2% | +8.1% | — |
| Aug 8, 2023 | AMC | -0.22 | -0.21 | +4.5% | 52.90 | +0.4% | +4.3% | +1.1% | -1.5% | -4.3% | -5.7% | — |
| May 9, 2023 | AMC | -0.20 | -0.13 | +35.0% | 65.40 | +2.1% | -0.2% | -2.9% | -6.0% | -6.7% | -9.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 | Brookline Capital | Upgrade | Hold → Buy | — | $8.05 | $8.69 | +8.0% | +0.7% | -2.9% | -1.7% | +2.0% | +3.5% |
| May 14 | Needham | Maintains | Hold → Hold | — | $5.50 | $5.50 | +0.0% | -2.7% | +16.7% | +20.4% | +17.1% | +16.9% |
| Apr 9 | Needham | Maintains | Hold → Hold | — | $5.79 | $5.77 | -0.3% | -20.0% | -23.5% | -16.4% | -4.5% | -14.9% |
| Apr 8 | HC Wainwright & Co. | Maintains | Neutral → Neutral | — | $6.45 | $6.51 | +0.9% | -10.2% | -28.2% | -31.3% | -25.0% | -14.3% |
| Mar 12 | Needham | Maintains | Hold → Hold | — | $6.48 | $6.29 | -2.9% | -7.6% | -8.8% | -17.1% | +0.5% | +0.3% |
| Dec 20 | Needham | Maintains | Hold → Hold | — | $6.76 | $6.80 | +0.6% | +2.7% | +4.1% | +1.5% | -4.0% | +1.2% |
| Nov 6 | HC Wainwright & Co. | Downgrade | Buy → Neutral | — | $7.98 | $8.36 | +4.8% | -6.5% | -11.8% | +4.0% | +20.6% | +15.3% |
| Nov 5 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $14.30 | $9.30 | -35.0% | -44.2% | -47.8% | -50.8% | -42.0% | -32.7% |
| Oct 21 | TD Cowen | Maintains | Buy → Buy | — | $16.00 | $16.00 | +0.0% | -1.9% | -0.6% | -5.6% | -6.2% | -5.6% |
| Oct 4 | RBC Capital | Maintains | Outperform → Outperform | — | $14.50 | $14.70 | +1.4% | -9.7% | -7.6% | -11.7% | -11.7% | -11.0% |
| Oct 3 | Needham | Downgrade | Buy → Hold | — | $11.10 | $11.00 | -0.9% | +30.6% | +18.0% | +20.7% | +15.3% | +15.3% |
| Oct 2 | Brookline Capital | Downgrade | Buy → Hold | — | $13.70 | $13.60 | -0.7% | -19.0% | +5.8% | -4.4% | -2.2% | -6.6% |
| Aug 15 | RBC Capital | Maintains | Outperform → Outperform | — | $31.20 | $33.40 | +7.1% | -6.7% | -10.3% | -5.1% | -9.3% | -6.7% |
| Aug 15 | Needham | Maintains | Buy → Buy | — | $31.20 | $33.40 | +7.1% | -6.7% | -10.3% | -5.1% | -9.3% | -6.7% |
| May 16 | Needham | Maintains | Buy → Buy | — | $91.00 | $89.70 | -1.4% | +0.5% | -4.7% | -4.4% | -3.6% | -0.5% |
| May 14 | Needham | Maintains | Buy → Buy | — | $95.60 | $99.40 | +4.0% | -0.7% | -4.8% | -4.3% | -9.3% | -9.0% |
| May 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $95.60 | $99.40 | +4.0% | -0.7% | -4.8% | -4.3% | -9.3% | -9.0% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $70.50 | $69.10 | -2.0% | +2.0% | +0.3% | -2.6% | -1.8% | -0.7% |
| Mar 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $52.70 | $54.20 | +2.8% | +5.3% | +5.3% | -2.5% | -5.7% | -7.8% |
| Mar 1 | Needham | Maintains | Buy → Buy | — | $52.70 | $54.20 | +2.8% | +5.3% | +5.3% | -2.5% | -5.7% | -7.8% |
| Dec 15 | Jefferies | Maintains | Buy → Buy | — | $37.60 | $42.00 | +11.7% | +62.0% | +47.9% | +47.9% | +49.7% | +70.5% |
| Nov 10 | Needham | Maintains | Buy → Buy | — | $32.10 | $31.80 | -0.9% | -4.2% | -6.2% | -8.7% | -1.2% | +8.1% |
| Oct 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $37.40 | $37.70 | +0.8% | -2.4% | -2.4% | -2.7% | -3.2% | -4.0% |
| Aug 23 | Needham | Maintains | Buy → Buy | — | $43.70 | $44.10 | +0.9% | +1.4% | -0.2% | +2.7% | +3.2% | +3.0% |
| Aug 10 | Needham | Maintains | Buy → Buy | — | $55.20 | $55.50 | +0.5% | -3.1% | -5.6% | -8.3% | -9.6% | -12.0% |
| Jul 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $53.10 | $55.80 | +5.1% | -2.4% | +8.9% | +10.0% | +5.6% | +1.3% |
| Jul 25 | Needham | Upgrade | Hold → Buy | — | $51.10 | $56.20 | +10.0% | +4.1% | +3.9% | +1.4% | +13.1% | +14.3% |
| Jul 25 | RBC Capital | Maintains | Outperform → Outperform | — | $51.10 | $56.20 | +10.0% | +4.1% | +3.9% | +1.4% | +13.1% | +14.3% |
| Jul 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $66.90 | $67.50 | +0.9% | +6.4% | +5.5% | +5.8% | +7.3% | +11.5% |
| Mar 22 | Jefferies | Maintains | Buy → Buy | — | $71.20 | $72.00 | +1.1% | -10.5% | -12.8% | -8.3% | -9.4% | -9.1% |
| Mar 7 | RBC Capital | Maintains | Outperform → Outperform | — | $72.70 | $72.10 | -0.8% | -7.7% | -6.2% | -9.1% | -9.8% | -11.0% |
| Feb 13 | RBC Capital | Upgrade | Sector Perform → Outperform | — | $71.00 | $79.20 | +11.5% | +1.8% | +1.3% | +6.2% | +3.0% | +11.5% |
| May 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $20.00 | $19.70 | -1.5% | -3.5% | -9.5% | -2.5% | +13.5% | +14.5% |
| May 25 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $55.60 | $26.10 | -53.1% | -63.8% | -64.7% | -64.0% | -65.3% | -67.4% |
| Mar 10 | Brookline Capital | Maintains | Buy → Buy | — | $79.60 | $80.70 | +1.4% | +0.4% | -1.0% | -3.4% | +0.1% | +0.8% |
| Mar 3 | Needham | Maintains | Buy → Buy | — | $85.90 | $88.30 | +2.8% | -1.9% | -5.2% | -10.6% | -10.4% | -7.3% |
| Sep 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $110.30 | $109.90 | -0.4% | +2.1% | +7.3% | +4.4% | +15.3% | +13.0% |
| Sep 21 | RBC Capital | Maintains | Outperform → Outperform | — | $120.30 | $92.50 | -23.1% | -8.3% | -6.4% | -1.7% | -4.3% | +5.7% |
| Sep 21 | Needham | Maintains | Buy → Buy | — | $120.30 | $92.50 | -23.1% | -8.3% | -6.4% | -1.7% | -4.3% | +5.7% |
| May 14 | RBC Capital | Maintains | Outperform → Outperform | — | $116.70 | $119.70 | +2.6% | +0.3% | +0.3% | -0.3% | -3.8% | -4.4% |
| Mar 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $136.80 | $142.10 | +3.9% | +5.7% | +10.4% | +25.7% | +22.5% | +23.8% |
| Feb 17 | Needham | Maintains | Buy → Buy | — | $140.50 | $141.20 | +0.5% | +9.8% | +4.0% | +6.0% | +4.6% | +0.4% |
| Jul 15 | BofA Securities | Downgrade | Buy → Neutral | — | $84.70 | $83.50 | -1.4% | -6.5% | -3.4% | +1.2% | -2.5% | -9.9% |
| Jun 30 | Needham | Maintains | Buy → Buy | — | $140.70 | $113.00 | -19.7% | -21.7% | -27.8% | -26.8% | -28.9% | -31.3% |
| Jun 30 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $140.70 | $113.00 | -19.7% | -21.7% | -27.8% | -26.8% | -28.9% | -31.3% |
| Jun 24 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $151.20 | $154.70 | +2.3% | -7.3% | -4.4% | -6.2% | -6.9% | -27.2% |
| Mar 24 | Needham | Maintains | Buy → Buy | — | $79.90 | $85.00 | +6.4% | +33.8% | +41.8% | +45.9% | +39.5% | +42.9% |
| Feb 21 | H.C. Wainwright | Maintains | Buy → Buy | — | $111.20 | $111.20 | +0.0% | -0.3% | -2.7% | -1.0% | -3.1% | -2.3% |
| Jul 10 | Jefferies | Maintains | Buy → Buy | — | $197.90 | $200.00 | +1.1% | -6.3% | -5.8% | -5.8% | -4.6% | -6.9% |
| Jul 10 | Cowen & Co. | Maintains | Outperform → Outperform | — | $197.90 | $200.00 | +1.1% | -6.3% | -5.8% | -5.8% | -4.6% | -6.9% |
No insider trades available.
Data updated apr 27, 2026 8:04am
· Source: massive.com